VBL Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference on Tuesday, November 29
November 23, 2016 10:51 ET
|
VBL Therapeutics
TEL AVIV, Israel, Nov. 23, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
VBL Therapeutics Announces Third Quarter 2016 Financial Results and Provides Business Update
November 10, 2016 07:00 ET
|
VBL Therapeutics
TEL AVIV, Israel, Nov. 10, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), today reported financial results and provided a business update for the third quarter and nine month period ended...
VBL Therapeutics to Report Third Quarter 2016 Financial Results on November 10
November 02, 2016 08:00 ET
|
VBL Therapeutics
TEL AVIV, Israel, Nov. 02, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
VBL Therapeutics Announces Plans to Establish New Manufacturing Facility
October 13, 2016 09:03 ET
|
VBL Therapeutics
TEL AVIV, Israel, Oct. 13, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), today announced that it has engaged in a long-term lease contract of a new stand-alone facility in Modiin,...
VBL Therapeutics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City on September 12th, 2016
September 06, 2016 08:00 ET
|
VBL Therapeutics
TEL AVIV, Israel, Sept. 06, 2016 (GLOBE NEWSWIRE) -- VBL THERAPEUTICS (NASDAQ:VBLT), today announced it will present at the 18th Annual Rodman & Renshaw Global Investment Conference, sponsored...
VBL Therapeutics Announces Second Quarter 2016 Financial Results and Provides Business Update
August 15, 2016 07:00 ET
|
VBL Therapeutics
TEL AVIV, Israel, Aug. 15, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
VBL Therapeutics to Report Second Quarter 2016 Financial Results on August 15
July 26, 2016 08:15 ET
|
VBL Therapeutics
TEL AVIV, Israel, July 26, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
VBL Therapeutics Announces Appointment of Dr. Rachel W. Humphrey to Head of the Scientific Advisory Board
June 21, 2016 07:00 ET
|
VBL Therapeutics
TEL AVIV, Israel, June 21, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
Vascular Biogenics Ltd. Closes $24 Million Registered Direct Offering
June 16, 2016 10:39 ET
|
VBL Therapeutics
TEL AVIV, Israel, June 16, 2016 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ:VBLT) announced that on June 10, 2016, it closed its previously...
VBL Therapeutics to Present Today at the 2016 BIO International Convention
June 07, 2016 08:00 ET
|
VBL Therapeutics
Dror Harats, CEO will discuss ASCO newly-reported VB-111 clinical data in Ovarian Cancer and rGBM TEL AVIV, Israel, June 07, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), announced...